| Hostnames |
approverx.com www.approverx.com www.aspn.co imperva.com therapatientsupportphysicianportal.com www.therapatientsupportphysicianportal.com |
| Domains | approverx.com aspn.co imperva.com therapatientsupportphysicianportal.com |
| Country | United States |
| City | Redwood City |
| Organization | Incapsula Inc |
| ISP | Incapsula Inc |
| ASN | AS19551 |
614661719 | 2024-10-19T03:51:32.76398925 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 58-180999390-0 0NNN RT(1729309889111 1072) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=58-180999390-0%200NNN%20RT%281729309889111%201072%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-954522701738804602&edet=3&cinfo=ffffffff&pe=610&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-954522701738804602</iframe></body></html>
-1936065286 | 2024-10-18T14:04:55.32003543 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 62-240212386-0 0NNN RT(1729260291989 21) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=62-240212386-0%200NNN%20RT%281729260291989%2021%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1373346733945718142&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1373346733945718142</iframe></body></html>
1169557418 | 2024-10-03T20:39:24.39302280 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 14-51526027-0 0NNN RT(1727987964128 17) q(0 -1 -1 -1) r(0 -1)
740908500 | 2024-10-27T20:58:48.40613881 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 10-102366173-0 0NNN RT(1730062728276 49) q(0 -1 -1 -1) r(0 -1)
-1669646077 | 2024-10-28T00:00:07.29343382 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 12-252802950-0 0NNN RT(1730073606735 6) q(0 -1 -1 -1) r(0 -1)
1408329136 | 2024-10-19T23:56:33.90039083 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 7-123671858-0 0NNN RT(1729382193604 2) q(0 -1 -1 -1) r(0 -1)
-1030984126 | 2024-10-26T16:34:29.93003784 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 6-92606871-0 0NNN RT(1729960469369 0) q(0 -1 -1 -1) r(0 -1)
-723604964 | 2024-10-30T22:05:18.12458388 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 16-301194248-0 0NNN RT(1730325917756 2) q(0 -1 -1 -1) r(0 -1)
-1152946712 | 2024-10-17T08:46:55.062069135 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 699 X-Iinfo: 11-50206016-0 0NNN RT(1729154814965 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=11-50206016-0%200NNN%20RT%281729154814965%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-238639992373839115&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-238639992373839115</iframe></body></html>
-2020468908 | 2024-10-20T00:19:56.559516389 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 61-258870129-0 0NNN RT(1729383595958 16) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=61-258870129-0%200NNN%20RT%281729383595958%2016%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1453138528996623741&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1453138528996623741</iframe></body></html>
90899183 | 2024-10-29T01:44:30.891333443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 13-10043112-0 0NNN RT(1730166270599 63) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1686371485 | 2024-10-30T20:11:41.449735444 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 13-24085615-0 0NNN RT(1730319100107 284) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-692025036 | 2024-10-03T05:50:23.866623465 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 696 X-Iinfo: 4-515684-0 0NNN RT(1727934617270 1206) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=24&xinfo=4-515684-0%200NNN%20RT%281727934617270%201206%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-2359050046276804&edet=3&cinfo=ffffffff&pe=610&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-2359050046276804</iframe></body></html>
575984734 | 2024-10-27T03:14:35.473065554 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 704 X-Iinfo: 6-101058536-0 0NNN RT(1729998874920 2) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=6-101058536-0%200NNN%20RT%281729998874920%202%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-500893195120804934&edet=3&cinfo=ffffffff&pe=892&rpinfo=0&mth=OPTIONS" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-500893195120804934</iframe></body></html>
1758548329 | 2024-10-14T00:38:33.212946587 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 15-137733398-0 0NNN RT(1728866309220 1020) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=15-137733398-0%200NNN%20RT%281728866309220%201020%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-687451872796869967&edet=3&cinfo=ffffffff&pe=631&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-687451872796869967</iframe></body></html>
-1093496457 | 2024-10-17T07:34:47.444660631 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 684 X-Iinfo: 0-7396805-0 0NNN RT(1729150487309 3) q(0 -1 -1 -1) r(0 -1)
676064487 | 2024-10-13T10:02:31.479545636 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 14-74185071-0 0NNN RT(1728813744752 271) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=24&xinfo=14-74185071-0%200NNN%20RT%281728813744752%20271%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-345369084063646926&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-345369084063646926</iframe></body></html>
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1302101724 | 2024-10-08T13:15:29.324460771 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 55-140893673-0 0NNN RT(1728393328818 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=55-140893673-0%200NNN%20RT%281728393328818%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-732814539894817911&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-732814539894817911</iframe></body></html>
-917667686 | 2024-10-29T10:39:37.1504221024 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 58-372961117-0 0NNN RT(1730198376445 19) q(0 -1 -1 -1) r(0 -1)
810004832 | 2024-10-24T12:15:30.3822381177 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 17-262486871-0 0NNN RT(1729772129711 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-if
-1439073560 | 2024-10-19T02:31:52.2134871234 / tcp
HTTP/1.0 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 15-175344510-0 0NNN RT(1729305112088 20) q(0 -1 -1 -1) r(0 -1)
-195679272 | 2024-10-31T02:39:12.5198011337 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 10-14054040-0 0NNN RT(1730342350697 308) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1111438439 | 2024-10-24T00:14:47.6657111400 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 56-205234837-0 0NNN RT(1729728886985 2) q(0 -1 -1 -1) r(0 -1)
1598233680 | 2024-10-24T04:50:10.7418891433 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 18-292213603-0 0NNN RT(1729745410366 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=18-292213603-0%200NNN%20RT%281729745410366%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1333540676391011474&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1333540676391011474</iframe></body></html>
-2099762777 | 2024-10-30T14:25:03.5650711443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 685 X-Iinfo: 8-5172150-0 0NNN RT(1730298303332 22) q(0 -1 -1 -1) r(0 -1)
-1670154095 | 2024-10-30T17:58:31.9840241521 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 696 X-Iinfo: 3-13675183-0 0NNN RT(1730311111813 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=3-13675183-0%200NNN%20RT%281730311111813%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-65519034675823811&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-65519034675823811</iframe></body></html>
-1285383470 | 2024-10-30T16:32:08.2640871935 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 685 X-Iinfo: 58-7252502-0 0NNN RT(1730305927548 2) q(0 -1 -1 -1) r(0 -1)
-1560384448 | 2024-10-17T09:33:47.1388472000 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 12-155899668-0 0NNN RT(1729157626217 1) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=12-155899668-0%200NNN%20RT%281729157626217%201%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-737196832469222988&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-737196832469222988</iframe></body></html>
-1859386992 | 2024-10-13T04:39:35.5573572082 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 14-73867171-0 0NNN RT(1728794369986 4961) q(0 -1 -1 -1) r(0 -1)
-482085776 | 2024-10-18T01:49:51.2844112083 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 62-244325840-0 0NNN RT(1729216190268 276) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
418300484 | 2024-10-25T07:17:41.7472962086 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 5-37500198-0 0NNN RT(1729840661643 5) q(0 -1 -1 -1) r(0 -1)
-1376876638 | 2024-10-28T16:56:38.2750822087 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 55-531182552-0 0NNN RT(1730134597613 163) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-86310363 | 2024-10-20T18:07:46.3240652222 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 15-136126839-0 0NNN RT(1729447665720 30) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=15-136126839-0%200NNN%20RT%281729447665720%2030%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-621176734958945487&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-621176734958945487</iframe></body></html>
843822214 | 2024-10-30T11:14:43.6193682345 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 14-21917096-0 0NNN RT(1730286882501 111) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=14-21917096-0%200NNN%20RT%281730286882501%20111%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-107297311614108814&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-107297311614108814</iframe></body></html>
1705346749 | 2024-10-28T22:37:33.6629012375 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 6-55555486-0 0NNN RT(1730155052930 35) q(0 -1 -1 -1) r(0 -1)
1505696604 | 2024-10-20T05:07:00.5206972376 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 61-497376587-0 0NNN RT(1729400819882 132) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1536849900 | 2024-10-30T16:21:00.1397002404 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 13-171091330-0 0NNN RT(1730305259468 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=13-171091330-0%200NNN%20RT%281730305259468%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-854104382437393613&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-854104382437393613</iframe></body></html>
-635406046 | 2024-10-22T03:59:34.8791732480 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 61-314818780-0 0NNN RT(1729569574201 0) q(0 -1 -1 -1) r(0 -1)
-621584134 | 2024-10-16T05:13:09.3988802628 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 16-154250703-0 0NNN RT(1729055588588 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=16-154250703-0%200NNN%20RT%281729055588588%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-696370828088050768&edet=3&cinfo=ffffffff&pe=610&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-696370828088050768</iframe></body></html>
-262813613 | 2024-10-17T04:35:36.6058182761 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 12-164113520-0 0NNN RT(1729139736192 184) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=12-164113520-0%200NNN%20RT%281729139736192%20184%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-791518350543750412&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-791518350543750412</iframe></body></html>
574722700 | 2024-10-26T15:25:01.4558432762 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 11-79028044-0 0NNN RT(1729956300781 21) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=11-79028044-0%200NNN%20RT%281729956300781%2021%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-424187024799106315&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-424187024799106315</iframe></body></html>
969100867 | 2024-10-25T18:05:07.2177643000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 13-216896607-0 0NNN RT(1729879506319 8) q(0 -1 -1 -1) r(0 -1)
69152054 | 2024-10-28T22:56:03.0961563001 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 10-165290390-0 0NNN RT(1730156161206 1) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=10-165290390-0%200NNN%20RT%281730156161206%201%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-785931783427262026&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-785931783427262026</iframe></body></html>
-1821954009 | 2024-10-16T00:12:07.0110713050 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 14-83168347-0 0NNN RT(1729037525824 330) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=14-83168347-0%200NNN%20RT%281729037525824%20330%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-414062691695854862&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-414062691695854862</iframe></body></html>
-1219244777 | 2024-10-13T09:32:04.0882433268 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 699 X-Iinfo: 3-128240785-0 0NNN RT(1728811923564 2) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=3-128240785-0%200NNN%20RT%281728811923564%202%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-633264752845325443&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-633264752845325443</iframe></body></html>
867917490 | 2024-10-09T19:08:29.6651873269 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 696 X-Iinfo: 37-912143-0 0NNN RT(1728500903056 430) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=24&xinfo=37-912143-0%200NNN%20RT%281728500903056%20430%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-5008644943119717&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-5008644943119717</iframe></body></html>
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-376371677 | 2024-10-14T10:39:02.1584993299 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 15-97236816-0 0NNN RT(1728902341418 18) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=15-97236816-0%200NNN%20RT%281728902341418%2018%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-447178101244560591&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-447178101244560591</iframe></body></html>
-854041075 | 2024-10-20T03:30:21.5068823333 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 4-199227077-0 0NNN RT(1729395021206 5) q(0 -1 -1 -1) r(0 -1)
1507743951 | 2024-10-24T00:58:13.0515613389 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 4-153976907-0 0NNN RT(1729731492120 38) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=4-153976907-0%200NNN%20RT%281729731492120%2038%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-718041587617170564&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-718041587617170564</iframe></body></html>
470264466 | 2024-10-19T22:04:45.7125323790 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 14-231672348-0 0NNN RT(1729375485507 60) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1875670073 | 2024-10-16T07:57:36.3452314000 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 14-200255761-0 0NNN RT(1729065455540 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=14-200255761-0%200NNN%20RT%281729065455540%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-954109495714120846&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-954109495714120846</iframe></body></html>
882518209 | 2024-10-28T03:28:56.7196854022 / tcp
HTTP/1.0 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 5-47933101-0 0NNN RT(1730086135845 123) q(0 -1 -1 -1) r(0 -1)
-1168618414 | 2024-10-06T07:41:05.5813704040 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 14-80716977-0 0NNN RT(1728200464984 0) q(0 -1 -1 -1) r(0 -1)
0 | 2024-10-19T21:05:44.6715734064 / tcp
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1329181532 | 2024-10-26T10:54:26.7337744443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 17-334863675-0 0NNN RT(1729940066063 69) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1231695123 | 2024-10-25T19:24:19.7991684444 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 12-231274815-0 0NNN RT(1729884258979 626) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
810994864 | 2024-10-19T20:22:42.0432054500 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 704 X-Iinfo: 62-287016945-0 0NNN RT(1729369361197 143) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=62-287016945-0%200NNN%20RT%281729369361197%20143%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1458844401654695550&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1458844401654695550</iframe></body></html>
1555137169 | 2024-10-16T16:35:44.7992434567 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 10-28962827-0 0NNN RT(1729096540496 3260) q(0 -1 -1 -1) r(0 -1)
2026374154 | 2024-10-31T01:21:56.3686784848 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 51-13134131-0 0NNN RT(1730337716188 16) q(0 -1 -1 -1) r(0 -1)
-2046149936 | 2024-10-29T13:14:26.2408134911 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 695 X-Iinfo: 14-696760-0 0NNN RT(1730207665450 76) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=24&xinfo=14-696760-0%200NNN%20RT%281730207665450%2076%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-3404113874453838&edet=3&cinfo=ffffffff&pe=631&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-3404113874453838</iframe></body></html>
-2085407345 | 2024-10-24T17:35:51.9607655000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 13-277031781-0 0NNN RT(1729791351044 17) q(0 -1 -1 -1) r(0 -1)
1034356435 | 2024-10-30T21:30:24.8361625001 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 14-7709915-0 0NNN RT(1730323823623 195) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1353503069 | 2024-10-26T03:54:10.6243485005 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 13-121710555-0 0NNN RT(1729914849866 1) q(0 -1 -1 -1) r(0 -1)
-1957111926 | 2024-10-27T06:45:28.5533535006 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 12-240196953-0 0NNN RT(1730011527574 62) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2147118583 | 2024-10-22T07:52:52.7370545007 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 18-308619456-0 0NNN RT(1729583571918 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=18-308619456-0%200NNN%20RT%281729583571918%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1464897728552633426&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1464897728552633426</iframe></body></html>
-564438946 | 2024-10-21T18:55:10.1999445010 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 699 X-Iinfo: 9-54034436-0 0NNN RT(1729536909542 21) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=9-54034436-0%200NNN%20RT%281729536909542%2021%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-245588408137942217&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-245588408137942217</iframe></body></html>
-50553418 | 2024-10-03T03:18:39.3739425201 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 699 X-Iinfo: 61-44549117-0 0NNN RT(1727925518389 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=61-44549117-0%200NNN%20RT%281727925518389%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-226928058939212925&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-226928058939212925</iframe></body></html>
702653368 | 2024-10-17T15:08:00.5659945222 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 7-106421491-0 0NNN RT(1729177680125 51) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=7-106421491-0%200NNN%20RT%281729177680125%2051%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-501042629889426631&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-501042629889426631</iframe></body></html>
-1042450729 | 2024-10-29T17:24:32.6192835555 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 32-62542038-0 0NNN RT(1730222672126 0) q(0 -1 -1 -1) r(0 -1)
2042305120 | 2024-10-26T03:51:06.4689645560 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 13-130895864-0 0NNN RT(1729914666100 2) q(0 -1 -1 -1) r(0 -1)
-1007592322 | 2024-10-29T01:59:07.8541955601 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 14-8839467-0 0NNN RT(1730167145772 743) q(0 -1 -1 -1) r(0 -1)
1273429938 | 2024-10-26T19:54:36.8583895672 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 12-246338150-0 0NNN RT(1729972476280 16) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=12-246338150-0%200NNN%20RT%281729972476280%2016%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1240863940793467980&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1240863940793467980</iframe></body></html>
1345969070 | 2024-10-21T00:20:15.6849305900 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 18-291907658-0 0NNN RT(1729470015598 15) q(0 -1 -1 -1) r(0 -1)
789247191 | 2024-10-28T04:17:38.4923345985 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 11-134654425-0 0NNN RT(1730089058407 0) q(0 -1 -1 -1) r(0 -1)
802451743 | 2024-10-28T00:06:11.4375595986 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 695 X-Iinfo: 13-296120410-0 0NNN RT(1730073968862 2322) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
162942465 | 2024-10-12T14:11:42.5646966000 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 16-139217803-0 0NNN RT(1728742302431 23) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=16-139217803-0%200NNN%20RT%281728742302431%2023%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-668003642405815376&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-668003642405815376</iframe></body></html>
1062251789 | 2024-10-18T07:12:20.4432076001 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 18-220092272-0 0NNN RT(1729235539809 11) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=18-220092272-0%200NNN%20RT%281729235539809%2011%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-994307997897589970&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-994307997897589970</iframe></body></html>
-1882892200 | 2024-10-28T15:01:05.8980766080 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 12-331281111-0 0NNN RT(1730127665391 33) q(0 -1 -1 -1) r(0 -1)
-1878277373 | 2024-10-22T23:47:28.9498166443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 14-163948315-0 0NNN RT(1729640848459 339) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-630081272 | 2024-10-19T06:54:13.7454177001 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 7-30571704-0 0NNN RT(1729320853284 343) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1982068310 | 2024-10-20T07:05:10.4136917071 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 10-48397581-0 0NNN RT(1729407909411 186) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1028826093 | 2024-10-25T22:09:17.8246367171 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 10-156220656-0 0NNN RT(1729894157622 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=10-156220656-0%200NNN%20RT%281729894157622%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-739985520450274570&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-739985520450274570</iframe></body></html>
2135451215 | 2024-10-28T07:24:18.4321307443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 62-736252993-0 0NNN RT(1730100257712 210) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1963296118 | 2024-10-30T23:20:37.0394397474 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 12-30272947-0 0NNN RT(1730330435767 453) q(0 -1 -1 -1) r(0 -1)
-1046410684 | 2024-10-14T20:57:27.2700607547 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 15-134051914-0 0NNN RT(1728939447125 43) q(0 -1 -1 -1) r(0 -1)
-1643920713 | 2024-10-28T13:45:57.9646617548 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 13-155311416-0 0NNN RT(1730123156516 587) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2145300207 | 2024-10-22T21:50:17.3443067777 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 4-46130828-0 0NNN RT(1729633816572 433) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-651054123 | 2024-10-17T21:02:46.9147327779 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 16-195512999-0 0NNN RT(1729198966741 26) q(0 -1 -1 -1) r(0 -1)
-92508727 | 2024-10-28T21:57:47.3847638000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 44-259438582-0 0NNN RT(1730152666884 0) q(0 -1 -1 -1) r(0 -1)
-1252409284 | 2024-10-28T12:59:19.3379258001 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 7-60697955-0 0NNN RT(1730120358955 6) q(0 -1 -1 -1) r(0 -1)
983353191 | 2024-10-24T07:27:33.0390078002 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 12-112541864-0 0NNN RT(1729754852060 270) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1929775231 | 2024-10-21T20:37:32.5584568008 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 11-155571791-0 0NNN RT(1729543052418 8) q(0 -1 -1 -1) r(0 -1)
1568218233 | 2024-10-28T13:02:30.4316998009 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 11-281926229-0 0NNN RT(1730120549801 158) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
668791609 | 2024-10-17T16:57:14.2211768010 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 16-156064964-0 0NNN RT(1729184233565 19) q(0 -1 -1 -1) r(0 -1)
690880778 | 2024-10-18T17:05:30.5015698060 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 52-273351207-0 0NNN RT(1729271129965 40) q(0 -1 -1 -1) r(0 -1)
726174539 | 2024-10-30T08:43:17.6948488069 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 683 X-Iinfo: 7-1334520-0 0NNN RT(1730277796867 31) q(0 -1 -1 -1) r(0 -1)
1784714564 | 2024-10-02T21:37:43.2144568080 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 686 X-Iinfo: 13-8666846-0 0NNN RT(1727905062339 51) q(0 -1 -1 -1) r(0 -1)
-103832196 | 2024-10-19T13:05:00.0330258081 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 16-227136217-0 0NNN RT(1729343099441 79) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1623612304 | 2024-10-26T05:05:20.8825468083 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 12-102193578-0 0NNN RT(1729919115097 5115) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-69902836 | 2024-10-16T10:23:36.7796768085 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 2-134991947-0 0NNN RT(1729074216415 94) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2135662494 | 2024-10-21T15:47:11.8167198086 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 4-212247238-0 0NNN RT(1729525631526 7) q(0 -1 -1 -1) r(0 -1)
-1494284495 | 2024-10-25T06:19:13.8530578089 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 695 X-Iinfo: 16-284396830-0 0NNN RT(1729837146494 6733) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
693974137 | 2024-10-31T02:31:44.4447788090 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 13-9699894-0 0NNN RT(1730341903122 303) q(0 -1 -1 -1) r(0 -1)
1141723929 | 2024-10-29T16:03:07.1663098098 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 685 X-Iinfo: 14-3618826-0 0NNN RT(1730217786656 7) q(0 -1 -1 -1) r(0 -1)
-1270162246 | 2024-10-30T10:12:07.4255958112 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 685 X-Iinfo: 57-2298413-0 0NNN RT(1730283127255 4) q(0 -1 -1 -1) r(0 -1)
-478417225 | 2024-10-15T18:37:18.4626348123 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 12-50717736-0 0NNN RT(1729017437587 0) q(0 -1 -1 -1) r(0 -1)
-1649297440 | 2024-10-15T13:13:27.1396828126 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 701 X-Iinfo: 13-69108310-0 0NNN RT(1728998006213 103) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=13-69108310-0%200NNN%20RT%281728998006213%20103%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-317036434582275149&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-317036434582275149</iframe></body></html>
-338124145 | 2024-10-29T08:01:05.0834598139 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 12-7788859-0 0NNN RT(1730188864514 59) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-676623334 | 2024-10-22T22:55:05.5691128140 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 693 X-Iinfo: 16-252289837-0 0NNN RT(1729637704658 83) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2054292214 | 2024-10-26T12:39:34.6371548181 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 3-76786184-0 0NNN RT(1729946373100 893) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-185856935 | 2024-10-29T13:39:31.8614178188 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 12-16385107-0 0NNN RT(1730209171639 24) q(0 -1 -1 -1) r(0 -1)
-1446123286 | 2024-10-29T09:18:55.1921728200 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 18-363500493-0 0NNN RT(1730193534826 0) q(0 -1 -1 -1) r(0 -1)
-1196694543 | 2024-10-25T22:55:34.2175088333 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 13-137819766-0 0NNN RT(1729896932729 421) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1953001671 | 2024-10-25T18:38:31.2792708443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 54-451019046-0 0NNN RT(1729881510608 158) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1789491022 | 2024-10-25T11:18:32.3867368545 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 16-255889711-0 0NNN RT(1729855111304 238) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1397880593 | 2024-10-25T12:11:08.6874138800 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 18-358549814-0 0NNN RT(1729858265089 2946) q(0 -1 -1 -1) r(0 -1)
1567886495 | 2024-10-29T11:43:59.5835878834 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 11-11829549-0 0NNN RT(1730202239330 57) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1751204768 | 2024-10-27T07:30:49.2668038880 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 17-322835137-0 0NNN RT(1730014248200 271) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
168559621 | 2024-10-29T19:25:03.7728308888 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 9-107658060-0 0NNN RT(1730229903165 57) q(0 -1 -1 -1) r(0 -1)
-538500756 | 2024-10-26T14:21:58.7996488889 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 13-132555765-0 0NNN RT(1729952517591 358) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-470633507 | 2024-10-23T23:22:17.3350908899 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 11-72450730-0 0NNN RT(1729725736016 509) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-871911613 | 2024-10-25T13:02:38.9463949000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 11-190655623-0 0NNN RT(1729861357973 56) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
774680674 | 2024-10-19T14:11:39.6712039001 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 17-195193335-0 0NNN RT(1729347098863 440) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-160874318 | 2024-10-30T20:35:06.4800759002 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 13-6657212-0 0NNN RT(1730320505006 370) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2105897514 | 2024-10-29T16:54:23.3528799009 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 686 X-Iinfo: 7-12687908-0 0NNN RT(1730220863125 48) q(0 -1 -1 -1) r(0 -1)
-1419833831 | 2024-10-28T17:51:35.4214099080 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 14-10907229-0 0NNN RT(1730137894678 20) q(0 -1 -1 -1) r(0 -1)
657408959 | 2024-10-19T00:51:43.3419509090 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 16-211390770-0 0NNN RT(1729299103269 1) q(0 -1 -1 -1) r(0 -1)
-244279439 | 2024-10-17T11:57:41.4881999091 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 12-151422318-0 0NNN RT(1729166261248 108) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-643019389 | 2024-10-23T06:07:21.5837629095 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 60-304901541-0 0NNN RT(1729663640612 263) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
259687979 | 2024-10-22T10:24:00.6155829100 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 703 X-Iinfo: 18-272467949-0 0NNN RT(1729592640009 11) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=18-272467949-0%200NNN%20RT%281729592640009%2011%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1232509972215235794&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1232509972215235794</iframe></body></html>
-1220956710 | 2024-10-29T05:24:20.6981739200 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 684 X-Iinfo: 6-2760023-0 0NNN RT(1730179460180 0) q(0 -1 -1 -1) r(0 -1)
1647215744 | 2024-10-28T05:06:21.7725879306 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 688 X-Iinfo: 13-8498994-0 0NNN RT(1730091978413 3159) q(0 -1 -1 -1) r(0 -1) <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=5&xinfo=13-8498994-0%200NNN%20RT%281730091978413%203159%29%20q%280%20-1%20-1%20-1%29%20r%280%20-1%29&incident_id=0-41942855327417613&edet=22&cinfo=ffffffff&rpinfo=0&mth=GET" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-41942855327417613</iframe></body></html>
536842976 | 2024-10-25T04:13:19.8121109398 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 17-269749787-0 0NNN RT(1729829599107 338) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1953703209 | 2024-10-20T14:39:54.6606439443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 16-171078856-0 0NNN RT(1729435193746 528) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1833096092 | 2024-10-12T15:31:58.5910629600 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 13-36530032-0 0NNN RT(1728747117462 13) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=13-36530032-0%200NNN%20RT%281728747117462%2013%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-203807171924854029&edet=3&cinfo=ffffffff&pe=575&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-203807171924854029</iframe></body></html>
475360364 | 2024-10-19T06:04:40.9588719876 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 704 X-Iinfo: 60-219018995-0 0NNN RT(1729317874979 153) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=60-219018995-0%200NNN%20RT%281729317874979%20153%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1137361027192587644&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1137361027192587644</iframe></body></html>
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
316998060 | 2024-10-21T04:11:01.6971519943 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 13-164003116-0 0NNN RT(1729483860460 627) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-678903536 | 2024-10-30T19:25:14.2740979998 / tcp
HTTP/1.1 408 Request Timeout Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 692 X-Iinfo: 11-13709017-0 0NNN RT(1730316308131 24) q(-1 -1 -1 -1) r(60 -1) b2 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=0&xinfo=11-13709017-0%200NNN%20RT%281730316308131%2024%29%20q%28-1%20-1%20-1%20-1%29%20r%2860%20-1%29%20b2&incident_id=0-65140875690312907&edet=4&cinfo=ffffffff&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-65140875690312907</iframe></body></html>
413255481 | 2024-10-22T12:51:28.2693629999 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 702 X-Iinfo: 57-201667521-0 0NNN RT(1729601487594 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=57-201667521-0%200NNN%20RT%281729601487594%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-1044687813472486713&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-1044687813472486713</iframe></body></html>
-708303357 | 2024-10-30T07:23:05.32019210000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 7-76273788-0 0NNN RT(1730272984604 218) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1198199983 | 2024-10-30T15:15:30.13635710001 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 696 X-Iinfo: 11-2936669-0 0NNN RT(1730301329004 1) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=11-2936669-0%200NNN%20RT%281730301329004%201%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-14272412652864843&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-14272412652864843</iframe></body></html>
1769267152 | 2024-10-21T15:24:35.66021010051 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 12-66726864-0 0NNN RT(1729524274488 292) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-2067028711 | 2024-10-30T11:22:29.47961110134 / tcp
\x15\x03\x01\x00\x02\x02F
1921100996 | 2024-10-04T03:44:03.98209110443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 16-21202075-0 0NNN RT(1728013442694 586) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:dc:6e:e8:d4:e0:06:c6:a6:cf:56:dc:c9:31:0b:a6
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 3 22:35:28 2024 GMT
Not After : Apr 1 22:35:28 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 3 22:35:28.973 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:72:79:3B:12:EF:8F:04:9F:27:4A:1F:BE:
F5:E8:72:F4:56:6A:4C:39:1D:BA:4D:77:4C:8F:EF:A3:
EC:27:23:19:02:20:77:B6:D9:47:39:6D:A2:17:0A:05:
2C:A9:9F:05:02:72:4D:DB:20:3C:2C:D2:90:1B:30:99:
52:23:62:EB:95:C8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 3 22:35:29.227 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:46:02:21:00:91:7B:45:32:85:54:E5:A4:36:F1:E6:
F2:F8:B3:C7:BB:75:28:04:8B:C3:DF:F3:D4:26:5C:3E:
13:04:F0:EE:7B:02:21:00:9E:76:09:DF:8F:A3:01:43:
B4:AD:D1:37:BF:76:13:85:DA:7D:91:9F:1C:65:A2:5D:
D3:C1:4D:58:10:FA:98:7B
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 3 22:35:29.441 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:03:06:13:64:BF:BC:85:BB:F6:3C:01:90:
49:E9:D7:E2:BB:97:0E:DF:85:72:85:40:23:93:F8:0A:
1A:04:82:BB:02:20:7C:25:B2:96:89:DA:75:D3:1E:F3:
64:D4:48:4E:A0:9B:91:10:EA:C4:E3:BA:27:63:C7:D7:
D7:6C:B9:5D:14:E1
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
19:bc:c0:5a:68:02:58:67:dd:6d:8f:a5:38:59:eb:57:0f:56:
5b:ca:15:c8:c1:41:93:ef:c7:08:46:44:27:5b:04:ad:8a:42:
03:be:4d:8a:47:07:05:b7:e2:44:82:53:77:f9:bc:43:78:c1:
c1:e9:5b:85:d4:b5:92:b7:4c:95:ec:05:ec:70:57:71:56:2c:
df:99:f0:9a:38:d3:f9:90:06:a0:9c:5c:b3:54:52:e5:a9:7b:
c2:e0:76:87:8c:f9:f8:4d:4e:71:9d:a7:25:62:87:bb:84:82:
e4:b1:01:a7:54:5b:de:21:ac:ae:ea:86:84:68:da:55:f1:d8:
50:9e:25:58:80:20:d6:17:b6:4a:5e:8a:3d:94:f9:47:ec:ad:
c0:f0:08:5b:b8:72:3b:d0:c1:7a:5b:ec:84:2b:5e:92:9b:21:
91:66:b9:40:b4:35:95:03:91:61:16:f9:2e:48:8d:41:52:72:
07:38:a8:6d:15:39:c7:86:06:4c:2b:86:d2:25:76:b2:a0:f3:
f0:38:c6:f7:43:16:a3:9a:ab:3f:bf:18:99:b0:99:80:ec:7e:
d9:49:11:60:f2:1c:12:f2:f0:75:e3:a3:e7:19:b0:52:1c:77:
dd:c1:b4:7a:6c:d2:19:69:e4:f6:9d:db:45:bc:09:ba:36:bb:
72:4b:8e:24
1490352131 | 2024-10-24T22:45:27.76961512345 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 699 X-Iinfo: 11-77401405-0 0NNN RT(1729809927097 1) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-ifr
-1821109920 | 2024-10-19T13:05:16.00769513047 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 689 X-Iinfo: 16-172699463-0 0NNN RT(1729343115122 0) q(0 -1 -1 -1) r(0 -1) <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=5&xinfo=16-172699463-0%200NNN%20RT%281729343115122%200%29%20q%280%20-1%20-1%20-1%29%20r%280%20-1%29&incident_id=0-835021937359389904&edet=22&cinfo=ffffffff&rpinfo=0&mth=GET" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-835021937359389904</iframe></body></html>
-433847285 | 2024-10-27T00:31:42.08325213579 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 17-304892605-0 0NNN RT(1729989101483 4) q(0 -1 -1 -1) r(0 -1)
-54081746 | 2024-10-24T09:32:34.51367614265 / tcp
''
-1250819380 | 2024-10-23T06:52:33.71413015443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 6-81523639-0 0NNN RT(1729666353089 286) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1039716076 | 2024-10-20T11:56:25.32672816010 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 14-146623931-0 0NNN RT(1729425385146 48) q(0 -1 -1 -1) r(0 -1)
269753646 | 2024-10-29T20:53:32.80146416030 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 47-324473917-0 0NNN RT(1730235212307 0) q(0 -1 -1 -1) r(0 -1)
126915652 | 2024-10-25T04:54:28.70983118080 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 16-255454618-0 0NNN RT(1729832066962 401) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
196681555 | 2024-10-30T22:09:24.83003418081 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 687 X-Iinfo: 2-9786276-0 0NNN RT(1730326163739 232) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1232964837 | 2024-10-30T14:09:05.51919020000 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 686 X-Iinfo: 12-1558270-0 0NNN RT(1730297343736 883) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1168216125 | 2024-10-23T02:32:00.69865528080 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 12-76209841-0 0NNN RT(1729650719920 404) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1859064321 | 2024-10-29T13:51:35.12783131337 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 694 X-Iinfo: 58-669063176-0 0NNN RT(1730209894443 190) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1778408876 | 2024-10-23T10:59:58.02446531443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 11-57686236-0 0NNN RT(1729681197263 388) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
1143850582 | 2024-10-25T22:03:50.55873750000 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 698 X-Iinfo: 6-94993985-0 0NNN RT(1729893829925 0) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=6-94993985-0%200NNN%20RT%281729893829925%200%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-501326969602508038&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-501326969602508038</iframe></body></html>
153699573 | 2024-10-22T23:34:19.62236755000 / tcp
HTTP/1.1 400 Bad Request Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 700 X-Iinfo: 14-166917271-0 0NNN RT(1729640059105 1) q(-1 -1 -1 -1) r(0 -1) b1 <html style="height:100%"><head><META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW"><meta name="format-detection" content="telephone=no"><meta name="viewport" content="initial-scale=1.0"><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"></head><body style="margin:0px;height:100%"><iframe id="main-iframe" src="/_Incapsula_Resource?CWUDNSAI=2&xinfo=14-166917271-0%200NNN%20RT%281729640059105%201%29%20q%28-1%20-1%20-1%20-1%29%20r%280%20-1%29%20b1&incident_id=0-807392803087844622&edet=3&cinfo=ffffffff&pe=544&rpinfo=0&mth=NA" frameborder=0 width="100%" height="100%" marginheight="0px" marginwidth="0px">Request unsuccessful. Incapsula incident ID: 0-807392803087844622</iframe></body></html>
-1461138345 | 2024-10-07T20:52:20.77074255443 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 691 X-Iinfo: 14-96228966-0 0NNN RT(1728334340062 461) q(0 -1 -1 -1) r(0 -1)
Certificate:
Data:
Version: 3 (0x2)
Serial Number:
01:8e:5f:36:2d:6d:09:8c:1a:2d:58:40:12:3b:0e:df
Signature Algorithm: sha256WithRSAEncryption
Issuer: C=BE, O=GlobalSign nv-sa, CN=GlobalSign Atlas R3 DV TLS CA 2024 Q3
Validity
Not Before: Oct 4 19:20:39 2024 GMT
Not After : Apr 2 19:20:39 2025 GMT
Subject: CN=imperva.com
Subject Public Key Info:
Public Key Algorithm: rsaEncryption
Public-Key: (2048 bit)
Modulus:
00:fc:98:7b:7f:e1:3a:16:34:76:44:de:08:73:72:
69:7e:ce:64:3b:85:a1:bc:14:f4:db:9c:31:16:7b:
09:ee:3f:11:7d:a3:57:11:7f:31:c6:8b:c2:63:19:
e6:60:57:41:de:9b:75:74:70:d9:e7:d8:22:e3:6a:
63:1f:f6:75:94:20:a0:9f:1a:4a:a9:97:ea:4d:6d:
ca:c1:73:41:73:71:9e:c1:e2:bf:56:e3:58:38:76:
1e:65:99:33:1d:20:14:fb:1a:a7:7c:8a:3b:b2:b4:
f7:10:29:99:c9:7b:ed:02:99:11:5c:1a:f0:d6:29:
ef:03:4e:5f:d2:46:b7:7f:25:25:cb:14:a1:d2:d3:
5f:36:2b:d7:1e:3e:f7:fe:6a:1c:f2:79:a3:d4:6a:
f2:ff:96:da:80:cf:25:88:61:40:b6:d7:89:3a:1f:
d9:f6:11:f2:3d:f6:9d:1f:fe:b9:f0:58:f8:fc:e5:
c8:e3:fb:18:49:d4:df:b2:a8:24:14:d3:2f:3e:96:
bd:1b:28:c0:bf:65:dd:dd:1a:0a:1a:c5:13:55:97:
8d:b3:d3:f6:38:c3:c0:d5:ae:e4:84:39:17:da:83:
1d:7d:c8:93:96:80:5f:b5:ad:d6:e2:1d:0e:46:ef:
2e:12:8e:e7:5c:71:9a:f8:4d:94:33:51:44:81:a4:
8b:25
Exponent: 65537 (0x10001)
X509v3 extensions:
X509v3 Subject Alternative Name:
DNS:approverx.com, DNS:*.bioridgepharma.com, DNS:therapatientsupportphysicianportal.com, DNS:www.approverx.com, DNS:www.aspn.co, DNS:www.therapatientsupportphysicianportal.com, DNS:imperva.com
X509v3 Key Usage: critical
Digital Signature, Key Encipherment
X509v3 Extended Key Usage:
TLS Web Server Authentication, TLS Web Client Authentication
X509v3 Subject Key Identifier:
EA:49:68:DA:D3:63:A6:97:CF:FF:AD:CC:62:4A:BD:BC:FE:4C:88:20
X509v3 Certificate Policies:
Policy: 2.23.140.1.2.1
Policy: 1.3.6.1.4.1.4146.10.1.3
CPS: https://www.globalsign.com/repository/
X509v3 Basic Constraints: critical
CA:FALSE
Authority Information Access:
OCSP - URI:http://ocsp.globalsign.com/ca/gsatlasr3dvtlsca2024q3
CA Issuers - URI:http://secure.globalsign.com/cacert/gsatlasr3dvtlsca2024q3.crt
X509v3 Authority Key Identifier:
65:E0:2A:53:1D:A7:47:F1:0D:31:80:3C:56:78:DB:EC:51:97:AC:33
X509v3 CRL Distribution Points:
Full Name:
URI:http://crl.globalsign.com/ca/gsatlasr3dvtlsca2024q3.crl
CT Precertificate SCTs:
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : CF:11:56:EE:D5:2E:7C:AF:F3:87:5B:D9:69:2E:9B:E9:
1A:71:67:4A:B0:17:EC:AC:01:D2:5B:77:CE:CC:3B:08
Timestamp : Oct 4 19:20:39.954 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:45:02:20:25:AE:9D:F3:80:72:CF:B6:0B:7A:44:05:
CE:42:E1:4D:83:7E:E2:63:13:E4:50:52:21:75:21:7A:
FE:05:D9:FE:02:21:00:8B:3A:27:58:19:E7:66:1F:5B:
86:DC:92:5E:52:B0:BE:33:E0:03:FF:91:98:E1:42:43:
DC:F4:50:64:6D:4E:26
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : A2:E3:0A:E4:45:EF:BD:AD:9B:7E:38:ED:47:67:77:53:
D7:82:5B:84:94:D7:2B:5E:1B:2C:C4:B9:50:A4:47:E7
Timestamp : Oct 4 19:20:40.077 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:39:D5:C3:4D:DC:2E:1C:F9:50:74:65:B4:
67:31:73:FD:A1:5E:8B:5C:39:08:90:E9:2B:3B:56:E8:
59:E3:A4:6E:02:20:3C:53:3C:F1:96:7D:46:5A:3B:4C:
15:24:03:17:4C:28:66:86:5C:9A:A0:78:D9:3B:BE:46:
09:65:BE:7C:F6:F8
Signed Certificate Timestamp:
Version : v1 (0x0)
Log ID : 13:4A:DF:1A:B5:98:42:09:78:0C:6F:EF:4C:7A:91:A4:
16:B7:23:49:CE:58:57:6A:DF:AE:DA:A7:C2:AB:E0:22
Timestamp : Oct 4 19:20:40.186 2024 GMT
Extensions: none
Signature : ecdsa-with-SHA256
30:44:02:20:42:B0:43:14:06:9B:52:B8:18:6D:C3:B9:
6A:EF:9B:F6:7A:9A:FD:1D:1C:6E:D2:D5:2F:AC:38:40:
8B:2B:83:DE:02:20:62:70:A9:E0:C0:90:11:32:AC:86:
49:BF:9D:B9:34:37:B8:8A:53:BA:49:01:02:AA:42:66:
8E:75:11:9A:55:A2
Signature Algorithm: sha256WithRSAEncryption
Signature Value:
55:22:f1:7a:81:a1:05:34:24:f4:10:85:25:c5:cb:bd:55:99:
a9:f3:77:0a:0f:f2:f7:42:d8:c6:2b:fd:16:e9:6b:27:df:d2:
4c:ca:20:e6:11:3a:1c:b3:55:3a:d1:6d:93:68:2a:e1:29:10:
bc:ab:e9:d5:23:55:ed:00:c9:33:69:48:6f:87:5c:2a:67:b6:
68:14:c5:58:98:30:75:98:8f:7b:f3:c4:6e:c3:be:bf:36:87:
66:ca:15:45:80:aa:ca:1f:d0:e7:54:5c:9c:8d:1e:01:31:84:
9c:a1:8b:8e:32:69:43:80:15:fc:3e:77:c0:40:bb:e5:05:f7:
a5:b9:ca:a0:66:1c:b7:c2:90:b5:0c:ee:9e:c3:ae:16:0d:23:
b6:2a:29:56:e6:2e:e2:05:ed:19:9d:87:1d:0f:d2:26:f3:15:
83:2e:3f:34:01:52:9c:32:d2:84:3a:a9:cb:92:cd:f3:8a:81:
9e:9b:27:37:4b:7b:21:f4:a7:7e:a2:86:16:dd:74:c8:16:8f:
28:64:65:2c:a7:09:68:f7:74:1e:63:ca:d5:1a:64:ff:03:af:
10:d7:4c:c5:65:35:05:4c:9d:fb:a1:c4:7d:cb:79:af:8b:cd:
29:07:1a:3d:52:68:f8:6c:2d:f2:9b:88:d0:35:19:b4:11:34:
d4:f7:a6:44
-1937087901 | 2024-10-24T08:56:59.23323060001 / tcp
HTTP/1.1 503 Service Unavailable Content-Type: text/html Cache-Control: no-cache, no-store Connection: close Content-Length: 690 X-Iinfo: 13-156916848-0 0NNN RT(1729760217392 38) q(0 -1 -1 -1) r(0 -1)